[go: up one dir, main page]

ES2103204B1 - Derivados quirales de hidroxifenilglicina y su empleo en la sintesis de principios activos farmaceuticos. - Google Patents

Derivados quirales de hidroxifenilglicina y su empleo en la sintesis de principios activos farmaceuticos.

Info

Publication number
ES2103204B1
ES2103204B1 ES09502328A ES9502328A ES2103204B1 ES 2103204 B1 ES2103204 B1 ES 2103204B1 ES 09502328 A ES09502328 A ES 09502328A ES 9502328 A ES9502328 A ES 9502328A ES 2103204 B1 ES2103204 B1 ES 2103204B1
Authority
ES
Spain
Prior art keywords
hydroxyphenylglycine
synthesis
active pharmaceutical
chiral derivatives
pharmaceutical principles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES09502328A
Other languages
English (en)
Other versions
ES2103204A1 (es
Inventor
Bayo Antonio Pallares
Morales Manuel Esteban
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Deretil SA
Original Assignee
DSM Deretil SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to ES09502328A priority Critical patent/ES2103204B1/es
Application filed by DSM Deretil SA filed Critical DSM Deretil SA
Priority to JP9520207A priority patent/JPH10513483A/ja
Priority to CA002211827A priority patent/CA2211827A1/en
Priority to CN96192156A priority patent/CN1176635A/zh
Priority to EP96939945A priority patent/EP0818438A1/en
Priority to AU76978/96A priority patent/AU7697896A/en
Priority to KR1019970705022A priority patent/KR19980701628A/ko
Priority to PCT/ES1996/000226 priority patent/WO1997019907A1/es
Priority to MXPA/A/1997/005687A priority patent/MXPA97005687A/es
Publication of ES2103204A1 publication Critical patent/ES2103204A1/es
Application granted granted Critical
Publication of ES2103204B1 publication Critical patent/ES2103204B1/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C229/36—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings with at least one amino group and one carboxyl group bound to the same carbon atom of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/006—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by reactions involving C-N bonds, e.g. nitriles, amides, hydantoins, carbamates, lactames, transamination reactions, or keto group formation from racemic mixtures
    • C12P41/009—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by reactions involving C-N bonds, e.g. nitriles, amides, hydantoins, carbamates, lactames, transamination reactions, or keto group formation from racemic mixtures by reactions involving hydantoins or carbamoylamino compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/04—Alpha- or beta- amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Signal Processing For Digital Recording And Reproducing (AREA)
  • Digital Magnetic Recording (AREA)

Abstract

DERIVADOS QUIRALES DE HIDROXIFENILGLICINA Y SU EMPLEO EN LA SINTESIS DE PRINCIPIOS ACTIVOS FARMACEUTICOS. LOS DERIVADOS QUIRALES DE HIDROXIFENILGLICINA, CON LA CONFIGURACION D, TIENEN LA FORMULA GENERAL (I), DONDE R ES H, HIDROXI, CLORURO, -NH2, -NHW, DONDE W ES UN GRUPO ALQUILO C1-C4 O ARILO, -OR", DONDE R" ES UN GRUPO ALQUILO C1-C4, Y Z ES H, -CONH2 Y -C(CH3)=CHCOOY, DONDE Y ES METILO O ETILO. UNO DE ESTOS COMPUESTOS, LA D-(-)-2-(2''-HIDROXIFENIL)GLICINA PUEDE OBTENERSE POR VIA ENZIMATICA A PARTIR DE LA HIDANTOINA CORRESPONDIENTE MIENTRAS QUE LOS OTROS PUEDEN OBTENERSE POR VIA QUIMICA O ENZIMATICA. LOS COMPUESTOS DE FORMULA (I) SON UTILES PARA LA PRODUCCION DE FARMACOS, EN PARTICULAR, PARA PENICILINAS SEMI-SINTETICAS, CEFALOSPORINAS, ANTIINFLAMATORIOS NO ESTEROIDEOS Y MUCOLICOS.
ES09502328A 1995-11-27 1995-11-27 Derivados quirales de hidroxifenilglicina y su empleo en la sintesis de principios activos farmaceuticos. Expired - Lifetime ES2103204B1 (es)

Priority Applications (9)

Application Number Priority Date Filing Date Title
ES09502328A ES2103204B1 (es) 1995-11-27 1995-11-27 Derivados quirales de hidroxifenilglicina y su empleo en la sintesis de principios activos farmaceuticos.
CA002211827A CA2211827A1 (en) 1995-11-27 1996-11-27 Chiral derivatives of hydroxyphenylglycine and their use in the synthesis of pharmaceutically active ingredients
CN96192156A CN1176635A (zh) 1995-11-27 1996-11-27 羟苯基甘氨酸的手性衍生物及其在药物活性成分合成中的用途
EP96939945A EP0818438A1 (en) 1995-11-27 1996-11-27 Chiral derivatives of hydroxyphenylglycin, and their use in the synthesis of pharmaceutical active principles
JP9520207A JPH10513483A (ja) 1995-11-27 1996-11-27 ヒドロキシフェニルグリシンのキラル誘導体、および薬剤活性成分の合成におけるその使用
AU76978/96A AU7697896A (en) 1995-11-27 1996-11-27 Chiral derivatives of hydroxyphenylglycin, and their use in the synthesis of pharmaceutical active principles
KR1019970705022A KR19980701628A (ko) 1995-11-27 1996-11-27 히드록시페닐글리신의 대장성유도체 및 이의 제약활성 성분 합성시 용도
PCT/ES1996/000226 WO1997019907A1 (es) 1995-11-27 1996-11-27 Derivados quirales de hidroxifenilglicina y su empleo en la sintesis de principios activos farmaceuticos
MXPA/A/1997/005687A MXPA97005687A (es) 1995-11-27 1997-07-25 Derivados quirales de hidroxifenilglicina y su empleo en la sintesis de principios activos farmaceuticos

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES09502328A ES2103204B1 (es) 1995-11-27 1995-11-27 Derivados quirales de hidroxifenilglicina y su empleo en la sintesis de principios activos farmaceuticos.

Publications (2)

Publication Number Publication Date
ES2103204A1 ES2103204A1 (es) 1997-08-16
ES2103204B1 true ES2103204B1 (es) 1998-04-01

Family

ID=8292294

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09502328A Expired - Lifetime ES2103204B1 (es) 1995-11-27 1995-11-27 Derivados quirales de hidroxifenilglicina y su empleo en la sintesis de principios activos farmaceuticos.

Country Status (8)

Country Link
EP (1) EP0818438A1 (es)
JP (1) JPH10513483A (es)
KR (1) KR19980701628A (es)
CN (1) CN1176635A (es)
AU (1) AU7697896A (es)
CA (1) CA2211827A1 (es)
ES (1) ES2103204B1 (es)
WO (1) WO1997019907A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102603449B (zh) * 2012-02-15 2015-07-15 河南新天地药业股份有限公司 一种左旋对羟基苯甘氨酸类化合物的合成方法
CN119899124A (zh) * 2025-01-18 2025-04-29 哈尔滨商业大学 一种次级代谢产物、制备方法及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4094741A (en) * 1976-02-04 1978-06-13 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Process for preparing D-(-)-N-carbamoyl-2-(phenyl or substituted phenyl)glycines
JPS63173595A (ja) * 1987-01-13 1988-07-18 Mitsui Toatsu Chem Inc Ｄ−α−アミノ酸の製造方法
NL9300422A (nl) * 1993-03-09 1994-10-03 Westspur Investment Ltd Werkwijze voor de bereiding van D-(-)-fenylglycinechloridehydrochloride.
WO1995025715A1 (en) * 1994-03-24 1995-09-28 Ciba-Geigy Ag Dl- di- or tri-hydroxyphenylglycine alkyl esters for the treatment of inflammatory and allergic conditions
CA2219944A1 (en) * 1995-05-19 1996-11-21 Miho Kobayashi 2-hydroxyphenylalkylamine derivatives and maillard reaction inhibitors

Also Published As

Publication number Publication date
CA2211827A1 (en) 1997-06-05
EP0818438A1 (en) 1998-01-14
WO1997019907A1 (es) 1997-06-05
MX9705687A (es) 1998-08-30
CN1176635A (zh) 1998-03-18
AU7697896A (en) 1997-06-19
ES2103204A1 (es) 1997-08-16
KR19980701628A (ko) 1998-06-25
JPH10513483A (ja) 1998-12-22

Similar Documents

Publication Publication Date Title
BR0010520A (pt) Novos compostos farmaceuticamente ativos
DK0580692T3 (da) Autoinducer
NO2595A (no) Anvendelse av en ringsystemforbindelse for fremstilling av et medikament
KR890701557A (ko) 리폭시게나제 억제화합물을 함유하는 푸란 및 피롤
BR0111754A (pt) Uso de um composto, método para inibir aurora 2 quinase em um animal de sangue quente, composto, e, composição farmacêutica
EA200000481A1 (ru) Производные гидроксамовой кислоты в качестве ингибиторов металлопротеаз матрикса (мпм)
ES2190115T3 (es) Derivados de acido hidroxamico y carboxilico con actividad inhibidora de mmp y tnf.
DK630489A (da) Substituerede 2-pyridoner og pyrid-2-thioner og deres anvendelse som laegemidler
DK0750631T3 (da) Mercaptoacetylamido-1,3,4,5-tetrahydrobenzo[c]azepin-3-ondisulfidderivater som enkephalinase- og ACE-inhibitorer
ES2169709A1 (es) Metodo para la preparacion de citalopram
KR880000400A (ko) 융합된 사이클릭 아제핀-2-온 유도체 및 그의 제조방법
KR930703303A (ko) 1, 4-벤조티아제핀 유도체
AU7517400A (en) N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent
ES557663A0 (es) Un procedimiento para la sintesis de derivados de imidazol.
HUP0100184A2 (hu) Szubsztituált 2-(benzil-amino)-2-fenil-acetamid-vegyületek és ezeket tartalmazó gyógyszerkészítmények
KR940005568A (ko) 1-아미노아세트아미도피롤, 1-아미노 아세트아미도-2-(치환된)피롤 및 관련 화합물
TW249804B (es)
BR0004534A (pt) Composto, composição farmacêutica, agente contendo um composto, e uso de um composto.
ES2103204B1 (es) Derivados quirales de hidroxifenilglicina y su empleo en la sintesis de principios activos farmaceuticos.
HUP9901212A2 (hu) N,N-dialkil-N-[2-(3-alkoxi-fenoxi)-etil]-amin-származékok, az ezeket tartalmazó gyógyszerkészítmények és helyi érzéstelenítőkként való alkalmazásuk
NO20001893L (no) FremgangsmÕte for behandling av dyskinesi relatert til sykdom eller som er indusert av medikamenter
ES2132245T3 (es) Derivados de 1-azaadamantano como agonistas o antagonistas de 5-ht.
DE3566664D1 (de) Substituted pyrazolin-5-one
ATE296115T1 (de) Ortsspezifische arzneimittel verabreichung
RU99100107A (ru) Производные дибензооксазепина и дибензодиоксепина и их применение в качестве противоопухолевых агентов

Legal Events

Date Code Title Description
PC2A Transfer of patent
EC2A Search report published

Date of ref document: 19970816

Kind code of ref document: A1

Effective date: 19970816

FA2A Application withdrawn

Effective date: 19990111